Last quarter (Q4 2023), Cumberland Pharmaceuticals's total revenue was $9.35M, an increase of 2.51% from the same quarter last year. In Q4, Cumberland Pharmaceuticals's net income was $-6.29M. See Cumberland Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 39.55M	$ 39.55M	$ 42.01M	$ 35.99M	$ 37.44M	$ 34.39M
Cost of Revenue	$ 6.07M	$ 6.07M	$ 9.12M	$ -8.81M	$ 8.65M	$ 7.42M
Gross Profit	$ 33.49M	$ 33.49M	$ 32.89M	$ 27.17M	$ 28.79M	$ 26.97M
Operating Expense	$ 42.69M	$ 42.69M	$ -38.60M	$ 36.26M	$ 35.17M	$ 36.26M
Operating Income	$ -9.55M	$ -9.55M	$ -5.70M	$ -9.09M	$ -6.38M	$ -9.29M
Net Non Operating Interest Income Expense	$ -381.01K	$ -381.01K	$ -487.59K	$ -71.95K	$ -188.28K	$ -2.82K
Other Income Expense	$ -2.83M	$ -2.83M	$ -611.33K	$ -2.93M	-	-
Pretax Income	$ -6.28M	$ -6.28M	$ -5.58M	$ -5.56M	$ -6.57M	$ -9.29M
Tax Provision	$ 45.77K	$ 45.77K	$ 68.85K	$ 34.89K	$ 55.90K	$ -79.32K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -6.85M	$ -6.28M	$ -5.57M	$ -4.18M	$ -3.34M	$ -3.54M
Basic EPS	$ -0.44	$ -0.44	$ -0.76	$ -0.24	$ -0.22	$ -0.23
Diluted EPS	$ -0.46	$ -0.44	$ -0.76	$ -0.24	$ -0.22	$ -0.23
Basic Average Shares	$ 57.20M	$ 14.30M	$ 14.56M	$ 14.90M	$ 15.16M	$ 15.40M
Diluted Average Shares	$ 57.20M	$ 14.30M	$ 14.56M	$ 14.90M	$ 15.16M	$ 15.40M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	$ -0.01	$ 0.32
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 48.76M	$ 48.76M	$ 47.10M	$ 27.45M	$ 43.82M	$ 43.68M
Net Income From Continuing And Discontinued Operation	$ -6.28M	$ -6.28M	$ -5.57M	$ -4.18M	$ -3.34M	$ -3.54M
Normalized Income	$ -6.57M	$ -6.69M	$ -40.72M	-	$ -6.55M	$ -9.20M
Interest Expense	-	-	-	-	$ 263.63K	$ 246.19K
EBIT	$ -5.62M	$ -5.62M	$ -5.00M	$ -5.46M	$ -6.31M	$ -9.04M
EBITDA	$ 168.84K	$ 168.84K	$ 344.16K	$ -823.78K	$ -1.56M	$ -4.64M

Currency in USD

Cumberland Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing